Table 1. Characteristics of Ukrainian patients, including hospital departments and microbiological findings, Frankfurt am Main, Germany, March–June 2022 (n = 103).
| Characteristic | n | % | 95%CI | |
|---|---|---|---|---|
| Patients (n = 103) | ||||
| Female | 57 | 55.3 | NA | |
| Male | 46 | 44.7 | NA | |
| Median age in years (standard deviation) | 39 years (23.7) | |||
| Department patients were admitted to | ||||
| Paediatric and adolescent medicine | 29 | 28.2 | 19.7–37.9 | |
| Gastroenterology | 12 | 11.7 | 6.2–19.5 | |
| Obstetrics and gynaecology | 11 | 10.7 | 5.4–18.3 | |
| Haematology/oncology | 9 | 8.7 | 4.1–15.9 | |
| General and visceral surgery; Trauma, hand and reconstructive surgery |
14 (7 each) | 6.8 | 2.8–13.5 | |
| Cardiology | 5 | 4.9 | 1.6–11.0 | |
| Otorhinolaryngology, head and neck surgery; Neurology |
8 (4 each) | 3.9 | 1.1–9.6 | |
| Vascular and endovascular surgery; Nephrology; Pneumology; Child and adolescent psychiatry, psychosomatics and psychotherapy |
8 (2 each) | 1.9 | 0.2–6.8 | |
| Othera | 7 | 6.8 | 2.8–13.5 | |
| Patients positive for | ||||
| MRSA | 0 | 0.0 | 0.0–3.5 | |
| ≥ 1 MDRGN isolate | 17 | 16.5 | 9.9–25.1 | |
| ≥ 1 CR isolate | 10 | 9.7 | 4.8–17.1 | |
| < 18 years of age among the CR-positive | 4 | 40.0 | 12.2–73.8 | |
| MDRGN isolates in Ukrainian patients (n = 34) | ||||
| CR | 21 | 61.8 | 43.6–77.8 | |
| Escherichia coli | ESBL, FQ | 8 | 23.5 | 10.7–41.2 |
| CR | 5 | 14.7 | 5.0–31.1 | |
| Carbapenemases (n) | NDM-5 (2); NDM-1 (1); OXA-48 (1); KPC-3 + NDM-5 (1) | |||
| Klebsiella pneumoniae | ESBL, FQ | 2 | 5.9 | 0.7–19.7 |
| CR | 6 | 17.6 | 6.8–34.5 | |
| Carbapenemases (n) | NDM-1 (2); NDM-1 + OXA-48 (3); NDM-1 + OXA-244 (1) | |||
| Enterobacter cloacae | Ceph, FQ | 2 | 5.9 | 0.7–19.7 |
| Acinetobacter baumannii | CR | 5 | 14.7 | 5.0–31.1 |
| Carbapenemase (n) | OXA-72 (3); OXA-23 (1); OXA-23 + OXA-72 (1) | |||
| Proteus mirabilis | Ceph, FQ | 1 | 2.9 | 0.0–15.3 |
| CR | 1 | 2.9 | 0.0–15.3 | |
| Carbapenemase (n) | NDM-1 (1) | |||
| Providencia stuartii | CR | 1 | 2.9 | 0.0–15.3 |
| Carbapenemase (n) | NDM-1 (1) | |||
| Pseudomonas aeruginosa | Pip, Ceph, FQ, CR | 3 | 8.8 | 1.9–23.7 |
| Carbapenemase (n) | NDM-1 (1); IMP-34 (1); GES-1 (1) | |||
Ceph: resistant to third/fourth generation cephalosporins; CI: confidence interval; CR: resistant to carbapenems; ESBL: extended spectrum beta-lactamase phenotype; FQ: resistant to fluoroquinolones; MDRGN: multidrug-resistant Gram-negative; MRSA: meticillin-resistant Staphylococcus aureus; Pip: resistant to piperacillin; NA: not available.
a Departments of urology, rheumatology, infectious diseases, ophthalmology, neurosurgery, psychiatry, psychosomatic medicine and psychotherapy and orthopaedics with n=1 each.